Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factorbeta1 expression, and increases Foxp3-expressing cells in localized scleroderma - Furuzawa-Carballeda, J; Ortiz-Avalos, M; Lima, G (Clin Exp Dermatol, 2012)
et al.